ELVN vs FBMS Comparison

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

First Bancshares Inc operates as a bank holding company. It offers various products and services such as deposit, including checking accounts, savings accounts, and time deposits account for individuals, businesses, associations and organizations, and governmental authorities. It also provides commercial and personal loans, including secured and unsecured loans, consumer loans, and loans for business expansion and purchase of equipment and machinery, and residential mortgage loans. The bank renders services like financial and wealth management, online internet banking, voice response telephone inquiry, safe deposit boxes, traveler's checks, and mobile deposit, and others. It operates in the Commercial/Retail Bank, Mortgage Banking, and Holding company segments.